MRK vs PODD
By Alex · Tickerpine
Merck & Company, Inc. vs Insulet Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | PODD |
|---|---|---|
| Price | $132.92 | $145.06 |
| Market cap | $327.94B | $10.06B |
| P/E ratio | 106.3 | 27.2 |
| ROE | 6.96% | 26.02% |
| Profit margin | 4.77% | 12.29% |
| Revenue growth | 5.10% | 23.50% |
| Dividend yield | 2.56% | — |
| Beta | 0.21 | 1.09 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs PODD in plain English
- MRK is the bigger company — about 32.6× the market cap of PODD.
- PODD is cheaper on earnings (P/E 27.2 vs 106.3).
- PODD earns a higher return on equity (26% vs 7%).
- PODD is growing revenue faster (24% vs 5%).
- MRK pays a dividend (2.56%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
PODD return calculator
See what $1,000 in Insulet Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.